Amarin (AMRN) IP Chief to Depart Company as AMR101 Exclusivity Still in Air
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Amarin Corporation plc (Nasdaq: AMRN) shares are trading lower Friday morning following reports of a management shakeup.
According to Bloomberg, Jonathon Rowe, head of Amarin's Intellectual Property and Portfolio Strategy will be departing the company to join another pharma firm.
His announcement will most likely come next week. The exec said Amarin has hired a patent attorney who previously worked at Sanofi-Aventis (NYSE: SNY).
Investors might be a little uneasy as market exclusivity for AMR101 still remains uncertain. In an August 29th note, Monness, Crespi, Hardt said it "remains unclear whether or not Amarin will be able to establish sufficiently long market exclusivity for the drug."
Amarin's applications with the U.S. Patent and Trademark Office for AMR101 for method-of-use patents have recently been rejected two further times, possibly promptin Rowe's departure.
Shares of Amarin are down 2 percent on Friday's session.
According to Bloomberg, Jonathon Rowe, head of Amarin's Intellectual Property and Portfolio Strategy will be departing the company to join another pharma firm.
His announcement will most likely come next week. The exec said Amarin has hired a patent attorney who previously worked at Sanofi-Aventis (NYSE: SNY).
Investors might be a little uneasy as market exclusivity for AMR101 still remains uncertain. In an August 29th note, Monness, Crespi, Hardt said it "remains unclear whether or not Amarin will be able to establish sufficiently long market exclusivity for the drug."
Amarin's applications with the U.S. Patent and Trademark Office for AMR101 for method-of-use patents have recently been rejected two further times, possibly promptin Rowe's departure.
Shares of Amarin are down 2 percent on Friday's session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Genworth Financial CEO returns from leave of absence in September
- Ingredion names Diego Reynoso as CFO, effective October 2026
Create E-mail Alert Related Categories
Insiders' Blog, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
